Ruchala Patsy L, Metheny Norma, Essenpreis Helen, Borcherding Kathleen
Graduate Nursing Programs, Georgia State University School of Nursing, Atlanta 30303, USA.
J Obstet Gynecol Neonatal Nurs. 2002 Sep-Oct;31(5):545-50. doi: 10.1111/j.1552-6909.2002.tb00079.x.
To determine the types of intravenous fluids used to dilute oxytocin for labor induction in a national sample of obstetric units, as well as the extent to which these fluids reflect current published guidelines.
A descriptive design.
Questionnaires were mailed to nurse managers at 700 obstetric units chosen via systematic random sampling from eligible hospitals listed in The AHA Guide (1998).
Two hundred fifty-six usable questionnaires were included in data analysis.
The Labor Induction Protocol Survey, consisting of eight questions relating to number of births per year, percentage of women whose labor is induced or augmented, methods used for induction of labor, intravenous fluids used to dilute oxytocin for induction of labor, the level of perinatal care of the unit, and the protocols units used to guide their practice in the use of oxytocin, was developed for this study.
Approximately 98% of the responding sites follow the current recommendations for oxytocin dilution and mainline fluid delivery. However, 5 or 2% of the sites reported the use of 5% dextrose in water for both oxytocin dilution and the mainline intravenous solution.
Although only 5 (2%) of the responding facilities indicated the use of 5% dextrose in water for both oxytocin dilution and the mainline intravenous solution, this may be clinically significant because of the serious nature of hyponatremia and the ease of its prevention. Nurses should be aware of the extent to which protocols for the infusion of oxytocin vary, despite what is documented as best practice and the potential consequences for their patients of implementing those protocols. Nurses who advocate for and participate in writing protocols that reflect the best-recommended practice for their patients will assist in ensuring that what is documented as best practice is actually implemented.
在全国范围内的产科单位样本中，确定用于稀释催产素以引产的静脉输液类型，以及这些输液符合当前已发表指南的程度。
描述性设计。
通过系统随机抽样从《美国医院协会指南》（1998年）列出的符合条件的医院中选取700个产科单位，并向其护士长邮寄问卷。
256份可用问卷纳入数据分析。
本研究制定了引产方案调查问卷，包括八个问题，涉及每年的分娩数量、引产或加强宫缩的妇女百分比、引产方法、用于稀释催产素以引产的静脉输液、单位的围产期护理水平以及单位用于指导催产素使用实践的方案。
约98%的回复单位遵循当前关于催产素稀释和主输液的建议。然而，5%（或2%）的单位报告在催产素稀释和主静脉输液中均使用5%葡萄糖溶液。
尽管只有5%（2%）的回复机构表示在催产素稀释和主静脉输液中均使用5%葡萄糖溶液，但由于低钠血症的严重性及其易于预防，这可能具有临床意义。护士应意识到，尽管记录了最佳实践，但催产素输注方案的差异程度以及实施这些方案对患者的潜在后果。倡导并参与制定反映其患者最佳推荐实践的方案的护士将有助于确保记录的最佳实践得到实际实施。
